ALUNGcancerdrug available on the NHS halves the risk of death, according to a study. Scientists say exciting study results show osimertinib will increase survival of thousands of British patients. 2 One study found that a lung cancer drug halves the risk of deathCredit: Getty 2 Osimertinib, sold under the name Tagrisso, is already available on the NHS for some patients It works by blocking vital receptors that allow cancer cells to use up energy to grow. The medicine is already being used for some NHS patients after previous research found…
Read More